Cambridge Cognition Holdings PLC is a neuroscience technology company specializing in the development and commercialization of digital solutions to assess and monitor brain health. Their flagship products, including the Cambridge Neuropsychological Test Automated Battery (CANTAB®), are used globally by pharmaceutical companies, academic researchers, and healthcare providers to quantify cognitive function in clinical trials, research studies, and clinical practice. The company aims to improve the understanding, diagnosis, and treatment of brain health disorders.
The headquarters serves as the central hub for research and development, product innovation, corporate strategy, financial operations, and global operational management.
Located in a modern business park setting, Tunbridge Court offers contemporary office spaces designed to support technology and research-driven companies. While specific architectural awards or unique internal features are not widely publicized, the facilities are understood to be well-equipped for a company focused on innovation and scientific development.
The work culture at Cambridge Cognition's HQ is characterized by a strong emphasis on scientific rigor, innovation, and collaboration. Employees, many with backgrounds in neuroscience and technology, work in a dynamic and intellectually stimulating environment focused on advancing brain health.
Its location within the Cambridge biotech and tech ecosystem provides access to world-class talent, research institutions (including proximity to Cambridge University), and potential partners, fostering innovation and maintaining its leadership in cognitive assessment technology.
Cambridge Cognition supports customers and clinical trials globally, with primary operational focuses in the United Kingdom, the United States, and Europe. Their digital cognitive assessment solutions are utilized in over 100 countries through direct engagement, strategic partnerships, and a network of distributors, enabling widespread application in academic research, clinical trials, and healthcare settings worldwide.
Tunbridge Court, Tunbridge Lane
Bottisham, Cambridge
Cambridgeshire
United Kingdom
Address: N/A (Distributed team primarily supporting US operations)
To expand Cambridge Cognition's market presence in North America, provide localized support to US-based clients, and facilitate the use of their cognitive assessment tools in clinical trials and research conducted in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cambridge Cognition' leadership includes:
Cambridge Cognition has been backed by several prominent investors over the years, including:
Over the past 12 months, Cambridge Cognition has experienced key leadership transitions, notably appointing a new Chief Financial Officer and seeing the departure of its Chief Commercial Officer and former CFO.
Discover the tools Cambridge Cognition uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Cambridge Cognition typically uses the email format [firstinitial][lastname]@cambridgecognition.com. While other formats might exist within the organization, this is a commonly observed structure.
[firstinitial][lastname]@cambridgecognition.com
Format
mstork@cambridgecognition.com
Example
85%
Success rate
London Stock Exchange (RNS) • April 26, 2024
Cambridge Cognition announced its audited final results for 2023, reporting revenue of £12.5 million and a contracted order book of £18.1 million. The company highlighted strategic progress and positive momentum carrying into 2024....more
Proactive Investors • March 26, 2024
Cambridge Cognition secured a significant contract worth approximately £1.2 million to provide its CANTAB™ cognitive assessments and eCOA platform for a late-phase schizophrenia clinical trial....more
Cambridge Cognition (RNS) • October 12, 2023
Cambridge Cognition announced the appointment of Nicklas Flodin as Chief Financial Officer, effective from January 2, 2024, succeeding Stephen Symonds....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cambridge Cognition, are just a search away.